Kim Eun Hee, Kim Joo Young, Lee Yoon Hee, Chong Gun Oh, Park Ji Young, Hong Dae Gy
Gynecologic Cancer Center, Kyungpook National University Medical Center, Daegu, Korea.
Department of Pathology, Kyungpook National University Medical Center, Daegu, Korea.
Obstet Gynecol Sci. 2014 Mar;57(2):144-50. doi: 10.5468/ogs.2014.57.2.144. Epub 2014 Mar 15.
This study was aimed to compare immunohistochemical expression of estrogen receptor (ER)-α, progesterone receptor (PR), and calponin in gonadotrophin-releasing hormone agonist (GnRH-a)-sensitive and -resistant uterine fibroids.
We collected data retrospectively. The sensitive group consisted of women who had reduction in uterine volume greater than 40% following GnRH-a treatment. Uterine volume was either reduced by less than 10%, or was increased in the resistant group. A tissue microarray was constructed using formalin-fixed, paraffin-embedded tissues, 31 and 26 patients for the sensitive and resistant groups, respectively. Tissue sections were immunostained with antibodies against ER-α, PR, and calponin. The intensity and area of the immunohistochemical reactions were evaluated using a semi-quantitative scoring system. The Mann-Whitney U-test, Fisher's exact test, and Spearman's rank correlation test were used for analysis of data.
PR (P = 0.04) and calponin (P = 0.03) showed a significantly higher staining intensity in the resistant group than in the sensitive group. Both groups showed comparable expression of ER-α (P = 0.23). In correlation analysis between changes in uterine volume after GnRH-a therapy and clinicopathological factors, the immunohistochemical intensity of PR (P = 0.04) and calponin (P = 0.03) was significantly correlated with changes in uterine volume.
This study shows that GnRH-a resistance of uterine fibroids is not related to ER-α content, but the expression of PR and calponin is related with GnRH-a resistance.
本研究旨在比较促性腺激素释放激素激动剂(GnRH-a)敏感型和抵抗型子宫肌瘤中雌激素受体(ER)-α、孕激素受体(PR)和钙调蛋白的免疫组化表达。
我们进行回顾性数据收集。敏感组由接受GnRH-a治疗后子宫体积缩小超过40%的女性组成。抵抗组子宫体积缩小小于10%或增大。使用福尔马林固定、石蜡包埋的组织构建组织芯片,敏感组和抵抗组分别有31例和26例患者。组织切片用抗ER-α、PR和钙调蛋白的抗体进行免疫染色。使用半定量评分系统评估免疫组化反应的强度和面积。采用曼-惠特尼U检验、费舍尔精确检验和斯皮尔曼等级相关检验进行数据分析。
PR(P = 0.04)和钙调蛋白(P = 0.03)在抵抗组中的染色强度显著高于敏感组。两组ER-α的表达相当(P = 0.23)。在GnRH-a治疗后子宫体积变化与临床病理因素的相关性分析中,PR(P = 0.04)和钙调蛋白(P = 0.03)的免疫组化强度与子宫体积变化显著相关。
本研究表明,子宫肌瘤的GnRH-a抵抗与ER-α含量无关,但PR和钙调蛋白的表达与GnRH-a抵抗有关。